Agnos Biosciences Launches AirSeq for Rapid DNA Air Sequencing with BBSRC Support
Agnos Biosciences has launched AirSeq, a rapid DNA air sequencing technology developed with support from the BBSRC, capable of identifying and quantifying thousands of airborne species, including bacteria and viruses. This validated technology, already in use in the UK, aims to improve biosecurity, public health, and agricultural practices.
Theia Market Signal Identification - AI Assisted
Agnos Biosciences, a spin-out supported by the Biotechnology and Biological Sciences Research Council (BBSRC), has introduced AirSeq, a rapid DNA air sequencing technology developed at the Earlham Institute and the Natural History Museum in London. AirSeq detects airborne biological material, enabling the simultaneous identification and quantification of thousands of species, including bacteria, viruses, fungi, and pollen, with a low false-positive rate.
The technology has been validated through research programs with the United States Defense Advanced Research Projects Agency. The licensing of AirSeq to Agnos allows for a fully integrated commercial service, with the technology already in use in the UK. This initiative aims to enhance biosecurity, public health, and agriculture.
Comments